| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/04/2006 | EP1611884A1 Patch containing nonsteroidal antiinflammatory and analgesic agent |
| 01/04/2006 | EP1611144A1 Derivatives of 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non-1(7)-en-2-yl)alkyl phosphonic acid and their use as n-methyl-d-aspartate (nmda) recetor antagonists |
| 01/04/2006 | EP1611130A2 Reverse-turn mimetics and method relating thereto |
| 01/04/2006 | EP1611124A1 Piperidine derivatives for the treatment of chemokine or h1 mediated disease state |
| 01/04/2006 | EP1611120A1 Novel methods for the treatment of inflammatory diseases |
| 01/04/2006 | EP1611100A1 Novel n-substituted 2-aminopyridine derivatives |
| 01/04/2006 | EP1611099A1 Novel 6-substituted 2-aminopyridine derivatives |
| 01/04/2006 | EP1611086A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 01/04/2006 | EP1611085A1 Biphenyl-carboxamide derivatives and their use as p38 kinase inhibitors |
| 01/04/2006 | EP1610793A2 Thiazoles useful as inhibitors of protein kinases |
| 01/04/2006 | EP1610792A1 Calcium channel blockers comprising two benzhydril moieties |
| 01/04/2006 | EP1610776A2 Ophthalmic compositions for treating ocular hypertension |
| 01/04/2006 | EP1434762A4 4'-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/04/2006 | EP1409455B1 Prostaglandin analogues-as ep4 receptor agonists |
| 01/04/2006 | EP1408030B1 Novel aliphatic compound, method of synthesis, and method of utilization |
| 01/04/2006 | EP1397153A4 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 01/04/2006 | EP1311677B1 Regulation of human p2y1-like g protein-coupled receptor |
| 01/04/2006 | EP1294725B1 Multicyclic compounds and their use as inhibitors of parp, vegfr2 and mlk3 enzymes |
| 01/04/2006 | EP1242403B1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 01/04/2006 | EP1212000B1 System for controlling body temperature while reducing shivering |
| 01/04/2006 | EP1169298B1 Pharmaceutical compounds |
| 01/04/2006 | EP1149116B1 Process for the production of multiple cross-linked hyaluronic acid derivatives |
| 01/04/2006 | EP1147088B1 6-arylphenanthridines with pde-iv inhibiting activity |
| 01/04/2006 | EP1083898B1 Novel use of hiv protease inhibiting compounds |
| 01/04/2006 | EP1070083B1 Crystalline forms of 1s- [1alpha (2s*,3r*), 9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9- [[(1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino [1, 2-a][ 1,2] diazepine-1-carboxamide |
| 01/04/2006 | EP0977562B1 Methods and compositions for delivery of taxanes |
| 01/04/2006 | EP0820286B1 Tetrandrine for the treatment for ocular inflammation |
| 01/04/2006 | CN1717409A Pyrazolonaphthyridine derivative |
| 01/04/2006 | CN1717397A 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 01/04/2006 | CN1717247A Composition comprising bamboo extract and the compounds isolated therefrom showing treating and preventing activity for inflammatory and blood circulation disease |
| 01/04/2006 | CN1717245A Medicinal composition |
| 01/04/2006 | CN1717228A Pharmaceutical composition comprising a LTB4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor |
| 01/04/2006 | CN1715290A Dengxin subergorgia saponin |
| 01/04/2006 | CN1715269A Cyanopyrrolidine derivatives |
| 01/04/2006 | CN1714861A Thymus penta peptide slow releasing micro ball and its preparing method |
| 01/04/2006 | CN1714860A Chinese medicine composition for dissolving stone, anti-inflammation, analgesia and bacteriostat and its preparing method |
| 01/04/2006 | CN1714856A Chinese medicine composition for treating rheumatoid arthritis and its preparing method |
| 01/04/2006 | CN1714846A Health medicinal wine for traumatic injury |
| 01/04/2006 | CN1714815A Bee glue and saussurea involucrata wine |
| 01/04/2006 | CN1714787A Tromethamine gel form medicinal composition |
| 01/04/2006 | CN1234712C 2-zminoalkyl-thieno [2, 3-D] pyrimidines |
| 01/04/2006 | CN1234707C Anti-cancer chemicals of methotrexate derivatives and their uses in pharmaceutical science |
| 01/04/2006 | CN1234705C New hydroxyl indoles, their use as phosphor diesterase 4 inhibitors and method for producing same |
| 01/04/2006 | CN1234698C Nitric oxide donors based on metallic centers |
| 01/04/2006 | CN1234693C Indazol compound for inhibiting protein kinase and medicine composition and their application |
| 01/04/2006 | CN1234688C 3-arylindole and their use as cb2 receptor agonists |
| 01/04/2006 | CN1234417C Pharmaceutical compositions comprising dendritic cells for immunotherapy of automimmune disease and treatment methods using the same |
| 01/04/2006 | CN1234406C Medicine for treating chronic pelvic inflammation and its preparing process |
| 01/04/2006 | CN1234401C Bi-ant contained dampness dispelling and collaterals dredging medicinal capsule |
| 01/04/2006 | CN1234388C External-use medicinal composition for treating gall |
| 01/04/2006 | CN1234375C Method for extracting active arthritis resisting element from Capparis fruit |
| 01/04/2006 | CN1234355C Medicinal composition having anti-inflammation and anti-infection function |
| 01/03/2006 | US6982335 Synthesis of substituted thiazoline carboxylic acids |
| 01/03/2006 | US6982320 Cytokine receptor common gamma chain like |
| 01/03/2006 | US6982319 Protein for use in the treatment of liver disorders, fibrosis, cancer, rheumatoid arthritis and glomeronephritis |
| 01/03/2006 | US6982286 Bicarbocyclic hydrazine/hydrazide compounds as inhibitors of semicarbazide-sensitive amine oxidases (SSAO), treat an inflammatory disease or condition, a disease related to carbohydrate metabolism, smooth muscle cell function |
| 01/03/2006 | US6982277 Antitumor agents, antiinflammatory agents; for example 2-(2-imino-4,5,6,7-tetrahydro-1,3-benzothiazol-3(2H)-yl)-1-(4-methylphenyl) -1-ethanone, 2-(4-methylphenyl)-5,6,7,8-tetrahydrobenzo(d)-imidazo(2,1-b)thiazole |
| 01/03/2006 | US6982274 excellent inhibitory action on protein phosphatase (protein kinase), especially on JNK protein kinase; therapeutic or prophylactic agents for immunologic disease, inflammatory disease and/or neurodegenerative disease |
| 01/03/2006 | US6982272 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis |
| 01/03/2006 | US6982270 1-Phenyl-2-oxo-3,4-dihydro-6-phenylaminoquinazoline for example; cytokine suppressive anti-inflammatory drugs; combination therapy |
| 01/03/2006 | US6982265 Pyrrolotriazine inhibitors of kinases |
| 01/03/2006 | US6982263 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 01/03/2006 | US6982253 Liquid formulation of decitabine and use of the same |
| 01/03/2006 | CA2343236C 4,4-biarylpiperidine derivatives |
| 01/03/2006 | CA2264901C Association of no syntase inhibitors with trappers of oxygen reactive forms |
| 01/03/2006 | CA2253635C Use of aspirochlorine or derivatives thereof as immunosuppressive agents |
| 01/03/2006 | CA2187449C Anti-cancer compounds containing cyclopentaquinazoline ring |
| 01/03/2006 | CA2132297C Pyrido[2,3-d]pyrimidine derivatives as phosphodiesterase inhibitors |
| 12/29/2005 | WO2005123777A2 Method of treating granuloma annulare or sarcoid |
| 12/29/2005 | WO2005123767A1 Peptide-based compounds |
| 12/29/2005 | WO2005123745A1 Tricyclic compounds |
| 12/29/2005 | WO2005123735A1 Process for producing evodiamine-containing composition |
| 12/29/2005 | WO2005123697A1 Quinazoline derivatives |
| 12/29/2005 | WO2005123675A1 Indoles useful in the treatment of inflammation |
| 12/29/2005 | WO2005123674A1 Indoles useful in the treatment of inflammation |
| 12/29/2005 | WO2005123673A1 Indoles useful in the treatment of inflammation |
| 12/29/2005 | WO2005123136A1 Antiinflammatory and analgesic preparation for external use |
| 12/29/2005 | WO2005123133A1 A process for preparing ibuprofen soft gelatin capsules |
| 12/29/2005 | WO2005123115A1 Methods of modulating cellular activity involving sphingosine kinase and agents for same, and sphingosine kinase variants |
| 12/29/2005 | WO2005123088A1 Solid orally ingestible formulations of tetrodotoxin |
| 12/29/2005 | WO2005123065A1 Chemokine receptor antagonistic medicinal composition |
| 12/29/2005 | WO2005123062A1 Inflammation inhibitor comprising zinc salt of acylamino acid |
| 12/29/2005 | WO2003012122A3 Crystallized structure of type iv collagen nc1 domain hexamer |
| 12/29/2005 | US20050289660 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 12/29/2005 | US20050289658 System for regulating in vivo the expression of a transgene by conditional inhibition |
| 12/29/2005 | US20050288501 Reducing a 2-(protected amino)-3-(piperazin-1-yl, N-morpholinyl, or N-thiomorpholinyl) propanoate, deprotecting the amine, and reacting with t-butylisothiocyanate |
| 12/29/2005 | US20050288487 Human mast cell-expressed membrane proteins |
| 12/29/2005 | US20050288376 Bicyclyl or heterobicyclylmethanesulfonylanimo-substituted N-hydroxyformamides |
| 12/29/2005 | US20050288368 Compositions and methods for treating and preventing necrosis |
| 12/29/2005 | US20050288366 Administering N-(4-carboxybutyl)-N-(p-carboxybenzyl)-benzyl- or phenethyl-amine derivatives: 4-({(4-Carboxybutyl)[3-(4-cyclohexylphenoxy)benzyl]amino}methyl)-benzoic acid; stimulate soluble guanylate cyclase also via a novel mechanism of action which takes place without involvement of the heme group |
| 12/29/2005 | US20050288363 Therapeutic compositions and methods of use |
| 12/29/2005 | US20050288357 e.g. 4-(2-{2-[4-hydroxy-4-(1-propylcyclobutyl)but-1-enyl]-5-oxopyrrolidin-1-yl}ethyl)benzoic acid; antiinflammatory, hypotensive, antiulcer agent |
| 12/29/2005 | US20050288340 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 12/29/2005 | US20050288337 Novel compounds |
| 12/29/2005 | US20050288324 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts |
| 12/29/2005 | US20050288320 Induce biosymthesis of cytokines, interferons, tumor necrosis factor; antitumor agents; viricides; chemical intermediates |
| 12/29/2005 | US20050288313 Synergistically combined with immunomodulators or antiinflammtory agents; treating rheumatoid arthritis; inhibiting organ transplant rejection; Janus Kinase 3 inhibitors such as CP 690550, 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile |
| 12/29/2005 | US20050288305 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 12/29/2005 | US20050288303 Cyclic protein tyrosine kinase inhibitors |
| 12/29/2005 | US20050288285 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |